(lp0
S'Why Anacor Pharmaceuticals, Inc. Stock Jumped 58.3% in May Motley Fool - Jun 5, 2016 What: Shares of Anacor Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing, and commercializing novel small-molecule therapeutics, shot up 58.3% last month, according to data from S&amp;P Global Market&nbsp;...'
p1
aS"Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move ... Motley Fool - May 24, 2016 On May 16, Pfizer announced that it was acquiring Anacor Pharmaceuticals  for the hefty sum of $99.25 in cash per share, or a 55% premium to where Anacor shares closed on Friday. The crown jewel of the $5.2 billion acquisition is&nbsp;..."
p2
aS'Apple Inc. and Anacor Pharmaceuticals Inc. Soar As Stocks Jump Motley Fool - May 16, 2016 After three consecutive weeks of declines, stocks started the new trading week on a much more positive note. On Monday, the Dow Jones Industrial Average  added 175 points, or 1%, and the S&amp;P 500  gained 20 points,&nbsp;...'
p3
aS'Pfizer buying Anacor Pharmaceuticals in $5.2-billion deal Los Angeles Times - May 16, 2016 Pfizer Inc. is acquiring Anacor Pharmaceuticals Inc., a California company with a potentially lucrative eczema treatment, in a deal valued at about $5.2 billion.'
p4
aS"Why Anacor Pharmaceuticals, Inc.'s Stock Skyrocketed Today Motley Fool - Jul 13, 2015 What: Shares of Anacor Pharmaceuticals  rose by over 40% today on heavy volume after the company released positive top-line results from two pivotal late-stage trials for crisaborole topical ointment as a treatment for mild-to-moderate&nbsp;...Wedbush On Anacor Pharma: Crisaborole Delivers, Reiterate Outperform - BenzingaAnacor Pharmaceuticals Inc  May Have A Home Run Drug On Its Hands - Smarter Analyst"
p5
aS"Why Anacor Pharmaceuticals, Inc. Shot Higher Motley Fool - Mar 13, 2015 Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis."
p6
aS"Anacor Pharmaceuticals Is Too Expensive Seeking Alpha - Jan 19, 2016 Sandoz is responsible for Kerydin's commercialization and Anacor is entitled to 50% of gross profit  and the company received $20 million in Q3 as Sandoz generated $40 million in sales. This represents an annual run rate ..."
p7
aS"Anacor Pharmaceuticals: The Devil You Don't Know Seeking Alpha - Jul 17, 2015 Anacor  is working toward bringing its boron-based topical anti-inflammatory phosphodiesterase 4 inhibitor  to the market."
p8
aS'Anacor Looks Much Better Now Seeking Alpha - Apr 7, 2016 The stock is down 30% since the call was made, and the company has raised capital through a convertible note offering, removing the financing overhang.'
p9
aS'With 365% stock climb, this Bay Area drug maker has skin in the game San Francisco Business Times  - Jul 31, 2015 Much of the stock boom came this month, after Palo Alto-based Anacor  announced early data from two studies of crisaborole - formerly known as AN-2728 - in people with raised, red, itchy and oozing blotches also known as atopic&nbsp;...'
p10
a.